https://wortmannininhibitor.co....m/trends-and-fits-as
Outcomes of 504 customers waitlisted with T-LVADs, the majority were transplanted (50%), bridged to CF-LVAD (17%), or recovered (9%). A total of 9047 recipients had been bridged to OHT during the study duration with 8875 CF-LVADs and 172 T-LVADs. Early success in propensity-matched T-LVAD ± T-RVAD patients ended up being similar to CF-LVAD ± T-RVAD patients but decreased at a 1-year follow-up. This difference in success at 1-year followup was attributable to significantly reduced survival in patients with c
إعجاب
علق
شارك
